Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $114.92 | $25.30 | 354.24% | 216.83x | 54.69x | 14.58x | 17.60x | 1.57x | $106.92M | 0.88% | $705.78M | 6.70 | $12.32B | 1,570.56 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.38 | $8.61 | 171.70% | 111.33x | 54.37x | 6.58x | 13.32x | 0.96x | $39.15M | 1.28% | $220.58M | 1.69 | $3.02B | 66.49 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $247.51 | $83.44 | 196.63% | 40.58x | 36.48x | 6.88x | 24.46x | 1.43x | $793.95M | 2.40% | $1.35B | 10.14 | $34.40B | 29.17 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.48 | $18.23 | 319.60% | 71.48x | 65.43x | 7.06x | 9.12x | 1.83x | $182.84M | 3.08% | $654.15M | 8.43 | $5.80B | 48.36 | ||
| RPRX | ROYALTY PHARMA PLC | $58.75 | $37.90 | 55.03% | 31.25x | 10.97x | 10.31x | 3.45x | 0.64x | $2.92B | 11.18% | $9.79B | 21.99 | $41.93B | 35.65 | ||
| VCEL | VERICEL CORP | $37.87 | $8.41 | 350.10% | 78.90x | 67.66x | 6.31x | 5.24x | 1.94x | $61.66M | 3.19% | $370.04M | 7.25 | $1.91B | 43.28 | ||
| KRYS | KRYSTAL BIOTECH INC | $345.55 | $88.71 | 289.55% | 41.78x | 44.27x | 23.16x | 7.53x | 2.22x | $257.78M | 2.53% | $1.36B | 46.03 | $9.81B | 42.05 | ||
| HALO | HALOZYME THERAPEUTICS INC | $107.00 | $71.45 | 49.75% | 30.06x | 11.85x | 7.54x | 84.60x | 0.61x | $806.22M | 6.43% | $143.54M | 1.22 | $14.13B | 19.66 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $65.51 | $19.82 | 230.49% | 172.39x | 22.50x | 3.72x | 2.01x | 1.13x | $738.18M | 5.83% | $6.32B | 32.68 | $15.99B | 41.47 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.06 | $8.01 | 50.57% | 12.69x | 11.08x | 5.24x | 3.29x | 1.11x | $82.01M | 11.49% | $217.65M | 3.68 | $572.34M | 7.40 | ||
| TECH | BIO-TECHNE CORP | $72.08 | $17.24 | 318.03% | 61.61x | 34.52x | 9.25x | 5.36x | 1.94x | $263.22M | 2.34% | $2.11B | 13.52 | $11.33B | 32.58 | ||
| TGTX | TG THERAPEUTICS INC | $55.39 | $23.59 | 134.76% | 17.98x | 55.74x | 9.82x | 14.04x | 2.00x | $17.39M | 0.22% | $604.08M | 4.26 | $8.75B | 62.83 | ||
| ADMA | ADMA BIOLOGICS INC | $9.39 | $7.34 | 27.87% | 13.04x | 11.80x | 4.18x | 5.15x | 0.76x | $116.47M | 5.43% | $408.21M | 1.79 | $2.16B | 9.29 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $240.48 | $187.32 | 28.38% | 15.76x | 9.41x | 3.30x | 3.25x | 0.66x | $1.62B | 10.66% | $4.80B | 75.98 | $18.39B | 11.37 | ||
| EXEL | EXELIXIS INC | $57.43 | $31.53 | 82.13% | 17.46x | 17.39x | 5.91x | 7.72x | 1.15x | $1.17B | 8.14% | $1.84B | 7.35 | $14.11B | 12.98 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.12 | $6.25 | -82.09% | 8.00x | -3.79x | 1.38x | 1.48x | 0.06x | $19.58M | 30.18% | $44.20M | 0.76 | $16.49M | 2.16 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $289.25 | $90.44 | 219.83% | 28.72x | 30.62x | 19.97x | 5.96x | 2.17x | $130.62M | 2.25% | $967.52M | 48.22 | $5.89B | 21.12 | ||
| MDXG | MIMEDX GROUP INC | $4.60 | $1.50 | 206.65% | 115.00x | -32.79x | 1.91x | 3.10x | 1.09x | $44.50M | 6.54% | $216.00M | 1.46 | $551.87M | 24.20 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $514.56 | $160.15 | 221.29% | 29.69x | 26.77x | 10.37x | 6.44x | 2.11x | $3.80B | 2.91% | $20.25B | 79.81 | $126.25B | 22.94 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $793.26 | $448.93 | 76.70% | 18.91x | 14.22x | 5.25x | 2.58x | 1.01x | $3.76B | 4.61% | $31.71B | 308.48 | $81.92B | 14.25 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $41.10 | $31.67 | 29.77% | 13.09x | 9.86x | 2.48x | 2.40x | 0.78x | $354.90M | 14.91% | $999.24M | 17.25 | $2.00B | 7.13 | ||
| UTHR | UNITED THERAPEUTICS CORP | $503.86 | $201.62 | 149.91% | 16.66x | 18.81x | 6.80x | 3.38x | 2.88x | $1.09B | 5.09% | $6.40B | 150.24 | $19.81B | 11.81 | ||
| INCY | INCYTE CORP | $123.28 | $62.00 | 98.85% | 15.18x | 34.77x | 4.24x | 3.94x | 1.71x | $1.92B | 7.77% | $6.34B | 31.66 | $21.04B | 10.17 | ||
| VCYT | VERACYTE INC | $42.03 | $7.13 | 489.77% | 29.19x | 40.20x | 5.98x | 2.43x | 116.09x | $165.99M | 4.94% | $1.39B | 17.36 | $3.12B | 22.32 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.